Market Dip? Here's Why This Bargain Biotech Is a Smart Buy Now
This company is a market leader -- and business is growing.
Better Growth Stock: Novavax vs. Teladoc
They both skyrocketed early in the pandemic.
Will Cardano Hit $3 in 2022?
One big catalyst this year may help.
The Biggest Challenge Solana Faces in 2022
It's one of the reasons behind recent declines.
The Worst Mistake Shiba Inu Investors Can Make Right Now
The popular meme token skyrocketed last year.
Where to Invest $5,000 for the Next 5 Years
Aim for companies with solid earnings prospects.
Should You Invest in Pfizer in 2022?
This may be another big year for coronavirus program revenue.
1 Green Flag for Novavax in 2022, and 1 Red Flag
The company has reached the coronavirus vaccine finish line.
The Worst Mistake Moderna Investors Can Make in 2022
It's important to look at the big picture.
Shiba Inu: Buy, Sell, or Hold in 2022?
This dynamic cryptocurrency already skyrocketed last year.
3 Reasons to Buy Teladoc in 2022
Teladoc has what it takes to deliver gains over the long term.
These Explosive Cryptocurrencies Could Beat Shiba Inu in 2022
They have plenty of momentum -- and elements that help them stand out from the crowd.
Could Novavax Go Parabolic?
The stock lost its luster last year -- but catalysts are ahead.
Could This Metaverse Crypto Be a Multibagger?
Rapper Snoop Dogg calls this place home.
Missed Out on Shiba Inu? Here's What to Buy Now
This player has a catalyst that may spark near-term and long-term gains.
Is Moderna Stock Too Expensive in 2022?
It's important to look at vaccine sales prospects -- and potential future products.
3 Cathie Wood Stocks That Could Deliver Bigger Gains Than the Market
They're all about innovation.
Should You Invest in Shiba Inu in 2022?
A catalyst may be on the way.
Novavax Stock: Buy, Sell, or Hold in 2022?
Revenue is right around the corner.
3 Cryptocurrencies That Could Dwarf Shiba Inu
They have what it takes to climb over the long term.